Should I, can I, dare I? Patients' view on stopping long-term antidepressant use, a qualitative study.

IF 1.6 4区 医学 Q2 Medicine
Acta Clinica Belgica Pub Date : 2022-12-01 Epub Date: 2022-01-10 DOI:10.1080/17843286.2021.2024384
Ellen Van Leeuwen, Sibyl Anthierens, Mieke L van Driel, An De Sutter, Rani De Beir, Thierry Christiaens
{"title":"Should I, can I, dare I? Patients' view on stopping long-term antidepressant use, a qualitative study.","authors":"Ellen Van Leeuwen,&nbsp;Sibyl Anthierens,&nbsp;Mieke L van Driel,&nbsp;An De Sutter,&nbsp;Rani De Beir,&nbsp;Thierry Christiaens","doi":"10.1080/17843286.2021.2024384","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aim: </strong>The rise in long-term antidepressant use is concerning. Long-term antidepressant (AD) use, much longer than recommended by guidelines, can result in risk of adverse events and generate unnecessary costs. In order to mitigate these risks, patients views about their antidepressants and how to discontinue need to be taken into account. We aimed to explore patients' experiences and views of discontinuing long-term AD, barriers and facilitators of discontinuation and required support.</p><p><strong>Methods: </strong>Semi-structured face to face interviews were conducted with 14 patients with long-term AD use in primary care. Interviews were analysed thematically.</p><p><strong>Results: </strong>Participants describe various perceptions about discontinuation. There is fear of returning to their depression, even in those who were ambivalent about the effectiveness and safety of AD continuation. Participants describe low confidence in their own coping resources, fear of stress, and previous negative experiences with stopping. This enhances their perception of AD dependence. Participants indicate the importance of the support of their GP and their social network to help them withdraw.</p><p><strong>Conclusion: </strong>Discontinuation of long-term antidepressants is a complex issue for patients. More awareness of the lack of evidence and the potential risks of long-term AD continuation is required. By raising the issue and offering support during discontinuation GPs can help their patients stop AD. A greater focus on non-pharmacological approaches of depression in primary care is needed to reduce unnecessary AD use.</p>","PeriodicalId":7086,"journal":{"name":"Acta Clinica Belgica","volume":" ","pages":"962-969"},"PeriodicalIF":1.6000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Clinica Belgica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17843286.2021.2024384","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/10 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2

Abstract

Background and aim: The rise in long-term antidepressant use is concerning. Long-term antidepressant (AD) use, much longer than recommended by guidelines, can result in risk of adverse events and generate unnecessary costs. In order to mitigate these risks, patients views about their antidepressants and how to discontinue need to be taken into account. We aimed to explore patients' experiences and views of discontinuing long-term AD, barriers and facilitators of discontinuation and required support.

Methods: Semi-structured face to face interviews were conducted with 14 patients with long-term AD use in primary care. Interviews were analysed thematically.

Results: Participants describe various perceptions about discontinuation. There is fear of returning to their depression, even in those who were ambivalent about the effectiveness and safety of AD continuation. Participants describe low confidence in their own coping resources, fear of stress, and previous negative experiences with stopping. This enhances their perception of AD dependence. Participants indicate the importance of the support of their GP and their social network to help them withdraw.

Conclusion: Discontinuation of long-term antidepressants is a complex issue for patients. More awareness of the lack of evidence and the potential risks of long-term AD continuation is required. By raising the issue and offering support during discontinuation GPs can help their patients stop AD. A greater focus on non-pharmacological approaches of depression in primary care is needed to reduce unnecessary AD use.

我应该,我能,我敢吗?患者对停止长期使用抗抑郁药的看法:一项定性研究。
背景与目的:长期抗抑郁药物使用的增加令人担忧。长期使用抗抑郁药(AD),远远超过指南建议的时间,可导致不良事件的风险,并产生不必要的费用。为了减轻这些风险,需要考虑患者对抗抑郁药的看法以及如何停用。我们的目的是探讨患者的经验和观点,停止长期阿尔茨海默病,障碍和促进停止和所需的支持。方法:对14例长期使用AD的初级保健患者进行半结构化面对面访谈。访谈按主题进行分析。结果:参与者描述了对停药的不同看法。即使是那些对阿尔茨海默病继续治疗的有效性和安全性持矛盾态度的人,也害怕回到抑郁状态。参与者描述了他们对自己的应对资源缺乏信心,对压力的恐惧,以及之前停止的负面经历。这增强了他们对AD依赖的感知。参与者表示,他们的全科医生和他们的社会网络的支持,以帮助他们退出的重要性。结论:长期抗抑郁药物的停药对患者来说是一个复杂的问题。需要更多地认识到证据的缺乏和长期AD持续的潜在风险。通过提出问题并在停药期间提供支持,全科医生可以帮助他们的患者停止AD。需要在初级保健中更多地关注抑郁症的非药物治疗方法,以减少不必要的阿尔茨海默病的使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Clinica Belgica
Acta Clinica Belgica 医学-医学:内科
CiteScore
2.90
自引率
0.00%
发文量
44
审稿时长
6-12 weeks
期刊介绍: Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine primarily publishes papers on clinical medicine, clinical chemistry, pathology and molecular biology, provided they describe results which contribute to our understanding of clinical problems or describe new methods applicable to clinical investigation. Readership includes physicians, pathologists, pharmacists and physicians working in non-academic and academic hospitals, practicing internal medicine and its subspecialties.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信